FDA Investigator Bernice F Hirsch
Bernice F Hirsch has inspections in 6 countries as of 15 Jun 2023. Bernice F Hirsch has collaborated with a combined 992 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
15 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Germany,
United Kingdom of Great Britain and Northern Ireland,
Singapore,
Italy,
Japan,
Taiwan
Co-Investigator(s):
Arsen Karapetyan,
Azza Talaat,
Bernice Hirsh,
Bruce H Mccullough,
Carl Lee,
CDR Rochelle B Young, RPh, MSA,
Darren S Brown,
Edith M Gonzalez,
Edwin Melendez,
Eric M Mueller, PharmD,
Erin D Mccaffery,
Haitao Li,
James C Maclaughlin,
Jane Chen,
Javier E Santos,
Jessica L Pressley,
Joey V Quitania,
Jose E Melendez, DDC,
Jose M Cayuela,
Jose O Hernandez,
Julianne C Mccullough,
Justin A Boyd,
Karen Takahashi,
Kevin A Gonzalez,
Kevin P Foley,
Kham Phommachanh,
Lata C Mathew, PhD,
Lisa M Bellows,
Maria A Reed,
Mark R Mcclain,
Mei Chiung J Huang,
Michael A Charles,
Michael R Goga,
Michele L Obert,
Miguel A Martinez,
Minh D Phan,
Mra Davism,
Nebil A Oumer,
Nicholas L Paulin,
Paraluman S Leonin,
Parul M Patel,
Patrick C Klotzbuecher,
Regina T Brown,
Samuel T Walker,
Sarah M Meng,
Sarah M Napier,
Seneca D Toms,
Sixto M Mercado Rios,
Steven D Kehoe,
Susanne M Richardson, MSc RAC ELS,
Ted L Anderson,
Timothy T Kapsala,
Tina M Pawlowski,
Truong Xuan Nguyen (Andy),
Walden H Lee,
Zhong Li, PhD
Bernice F Hirsch's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2003 | FDA 483 | TEVA PFC - Form 483, 2003-04-02 |
March, 2003 | FDA 483 Response | BASF Grenzach GmbH - Form 483R, 2003-04-03 |
April, 2003 | FDA 483 Response | Flamma SpA - Form 483R, 2003-04-30 |
March, 2003 | EIR | BASF Grenzach GmbH - EIR, 2003-03-20 |
April, 2003 | EIR | Flamma SpA - EIR, 2003-04-02 |
May, 2002 | EIR | Glaxo Wellcome Manufacturing Pte. Ltd - EIR, 2002-05-30 |
May, 2004 | EIR | Eli Lilly and Company Limited - EIR, 2004-05-06 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more